Mu Guangyan, Xiang Qian, Zhou Shuang, Xie Qiufen, Liu Zhiyan, Zhang Zhuo, Cui Yimin
Department of Pharmacy, Peking University First Hospital, 6# Dahongluochang Street, Xicheng District, Beijing, 100034, PR China.
Pharmacogenomics. 2019 Feb;20(3):189-212. doi: 10.2217/pgs-2018-0157. Epub 2019 Jan 23.
Genetic polymorphisms may influence the incidence of angiotensin-converting enzyme (ACE) inhibitor-induced cough. This study aims to investigate this association.
Ten electronic databases and PharmGKB were systematically searched. Pooled odds ratio values and their 95% CI were used to assess the association, using the random-effects model.
A total of 26 studies were included in the review, 17 of them were included from two separated meta-analysis (ACE I/D or BDKRB2-58T/C). Significant association was found between ACE I/D I carriers (ACE gene insertion) and ACE inhibitor-induced cough, showing racial and age differences.
This study demonstrated that ACE I/D but not BDKRB2-58T/C polymorphism could be a predictor for the risk of ACE inhibitor-induced cough, especially in east Asians and the aged.
基因多态性可能影响血管紧张素转换酶(ACE)抑制剂所致咳嗽的发生率。本研究旨在调查这种关联。
系统检索了10个电子数据库和PharmGKB。采用随机效应模型,合并比值比及其95%置信区间来评估这种关联。
本综述共纳入26项研究,其中17项来自两项独立的荟萃分析(ACE I/D或BDKRB2 - 58T/C)。发现ACE I/D I携带者(ACE基因插入)与ACE抑制剂所致咳嗽之间存在显著关联,呈现种族和年龄差异。
本研究表明,ACE I/D而非BDKRB2 - 58T/C多态性可能是ACE抑制剂所致咳嗽风险的一个预测指标,尤其是在东亚人和老年人中。